Peptides ~ GMP Custom Manufacturing ..

Over 6,500 products including amino acid derivatives, resins and reagents for synthesis and more than 4,000 peptides, biochemicals, substrates & inhibitors for research use have been listed in Bachem’s catalog.

Auspep's GMP facility is the only TGA registered peptide manufacturing plant in Australia

Dr. Michael Pennington joined Peptides International in December 2010 as Chief Technology Officer. On January 1, 2013, Dr. Pennington's role became that of President and Chief Executive Officer. After doctoral research at University of Florida, he joined the pharmaceutical industry in the Department of Biotechnology at Schering-Plough. He joined Bachem Biosciences in King of Prussia, PA as a Principle Scientist in the Peptide Chemistry department. Dr. Pennington served as the Group Director for Bachem Biosciences before being appointed as President and C.O.O., a positioned he maintained from 2000 – 2010. He built and directed an internationally recognized peptide chemistry team focused on producing complex peptides and toxins. Dr. Pennington was a member of Bachem Forschungausschuss, the International Research and Development from 2000 – 2010. He has extensive collaborations with both industrial and academic scientists and maintains an extramurally funded research program on several peptide toxins. He is a founder of Airmid Inc., a biotech venture company dedicated to advancing two of his discoveries into clinical development for autoimmune diseases. Dr. Pennington has been awarded four patents and over 85 peer reviewed scientific articles, and serves as an editor of International Journal of Peptide Research and Therapeutics and Current Peptide and Protein Letters. He holds a Bachelor of Chemistry degree from the University of North Carolina at Chapel Hill and a Ph.D. from University of Florida at Gainesville.


Custom GMP synthetic peptide manufacturing from ..

We can manufacture GMP peptides as active pharmaceuticals and for clinical trials over a wide range of scales.

It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients.


for example, for peptide synthesis, explains the Bachem ..

Dr. Michael Pennington joined Peptides International in December 2010 as Chief Technology Officer. On January 1, 2013, Dr. Pennington's role became that of President and Chief Executive Officer. After doctoral research at University of Florida, he joined the pharmaceutical industry in the Department of Biotechnology at Schering-Plough. He joined Bachem Biosciences in King of Prussia, PA as a Principle Scientist in the Peptide Chemistry department. Dr. Pennington served as the Group Director for Bachem Biosciences before being appointed as President and C.O.O., a positioned he maintained from 2000 – 2010. He built and directed an internationally recognized peptide chemistry team focused on producing complex peptides and toxins. Dr. Pennington was a member of Bachem Forschungausschuss, the International Research and Development from 2000 – 2010. He has extensive collaborations with both industrial and academic scientists and maintains an extramurally funded research program on several peptide toxins. He is a founder of Airmid Inc., a biotech venture company dedicated to advancing two of his discoveries into clinical development for autoimmune diseases. Dr. Pennington has been awarded four patents and over 85 peer reviewed scientific articles, and serves as an editor of International Journal of Peptide Research and Therapeutics and Current Peptide and Protein Letters. He holds a Bachelor of Chemistry degree from the University of North Carolina at Chapel Hill and a Ph.D. from University of Florida at Gainesville.

Novabiochem® Peptide and DNA Synthesis Reagents - …

Choosing a reliable partner for your custom peptide synthesis needs is a critical decision. One must carefully weigh the quality, quantity and complexity of their custom peptide to the capabilities of their CMO. At Peptides International, we have a dedicated team of peptide and organic chemists to tackle the most complicated custom peptide synthesis demands. Our experience is unsurpassed in terms of knowledge and capabilities in producing cyclic RGD, disulfide-rich, dye-labelled, stapled, pegylated and lipidated peptides. Our facilities allow for seamless scale-up of your custom peptide from small milligram quantities to 1-2 kg levels. Furthermore, if you need cGMP synthesis as your custom peptide advances into the clinic, we do offer a complete tech-transfer with our partner Peptisyntha that is part of the Corden Pharma group. Lastly, as part of our custom peptide synthesis service, we have a dedicated project manager with whom you will get regular updates regarding your project. We offer all of this to you at extremely competitive prices. Give us a try for your next custom peptide synthesis project. We promise you will not be disappointed!

for example for peptide synthesis.

Auspep's GMP facility is the only TGA registered peptide manufacturing plant in Australia. The purpose-built manufacturing facility combined with our scientific expertise means we are able to provide a full range of GMP services to meet the most exacting regulatory requirements.